Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology

Nicolas Bertrand; Jun Wu; Xiaoyang Xu; Nazila Kamaly; Omid C. Farokhzad

doi:10.1016/j.addr.2013.11.009

Keywords

CommercializationNanomedicineMedicineNanotechnologyTolerabilityCancerDrug developmentPersonalized medicineDrugPharmacologyNanoparticleBioinformaticsInternal medicineBusinessAdverse effectMaterials scienceBiology

Affiliated Institutions

Related Publications

Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance

Yihan Yao , Yunxiang Zhou , Lihong Liu +7 more

Nanotechnology has been extensively studied and exploited for cancer treatment as nanoparticles can play a significant role as a drug delivery system. Compared to conventional d...

2020 Frontiers in Molecular Biosciences 1315 citations

Tumor targeting via EPR: Strategies to enhance patient responses

Susanne K. Golombek , Jan‐Niklas May , Benjamin Theek +4 more

2018 Advanced Drug Delivery Reviews 1142 citations

Smart cancer nanomedicine

Roy van der Meel , Einar Sulheim , Yang Shi +3 more

2019 Nature Nanotechnology 1125 citations

The enhanced permeability retention effect: a new paradigm for drug targeting in infection

Ernest Azzopardi , Elaine L. Ferguson , David W. Thomas

Multidrug-resistant, Gram-negative infection is a major global determinant of morbidity, mortality and cost of care. The advent of nanomedicine has enabled tailored engineering ...

2012 Journal of Antimicrobial Chemotherapy 295 citations

Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization

Susan Hua , María Matos , Josbert M. Metselaar +1 more

The use of nanotechnology in medicine has the potential to have a major impact on human health for the prevention, diagnosis, and treatment of diseases. One particular aspect of...

2018 Frontiers in Pharmacology 855 citations

Publication Info

Year: 2013
Type: review
Volume: 66
Pages: 2-25
Citations: 2679
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

2679

OpenAlex

Cite This

APA Style

                            
                                    Nicolas Bertrand, 
                                
                                    Jun Wu, 
                                
                                    Xiaoyang Xu
                                
                                et al.
                            
                            (2013). 
                            Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology. 
                            Advanced Drug Delivery Reviews
                            , 66
                            
                            , 2-25.
                            https://doi.org/10.1016/j.addr.2013.11.009

Identifiers

DOI: 10.1016/j.addr.2013.11.009